Peripheral expression of MAPK pathways in Alzheimer's and Parkinson's diseases

Journal of Clinical Neuroscience

Volumn 21, Issue 5, 2014, Pages 810-814

  Wang, Shan ^a   Zhang, Chong ^a   Sheng, Xiaona ^a   Zhang, Xiaowei ^a   Wang, Binbin ^a   Zhang, Guohua ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; c Jun N terminal kinase; Mitogen activated protein kinase; Parkinson's disease; Peripheral blood lymphocytes

Indexed keywords

BIOLOGICAL MARKER; MITOGEN ACTIVATED PROTEIN KINASE P38;

AGED; ALZHEIMER DISEASE; BIOSYNTHESIS; BLOOD; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; MALE; PARKINSON DISEASE; PHYSIOLOGY; SIGNAL TRANSDUCTION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PARKINSON DISEASE;

EID: 84898598303     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2013.08.017     Document Type: Article

References (29)

1. Bialopiotrowicz E, Kuzniewska B, Kachamakova-Trojanowska N, et al. Cell cycle regulation distinguishes lymphocytes from sporadic and familial Alzheimer's disease patients. Neurobiol Aging 2011;32:2319.e13-26.
2. L. Molochnikov, J.M. Rabey, and E. Dobronevsky et al. A molecular signature in blood identifies early Parkinson's disease Mol Neurodegener 7 2012 26
3. K.A. Jellinger, and C. Stadelmann Problems of cell death in neurodegeneration and Alzheimer's disease J Alzheimers Dis 3 2001 31 40
4. R. Herrera-Molina, B. Flores, and J.A. Orellana et al. Modulation of interferon-γ-induced glial cell activation by transforming growth factor β1: a role for STAT1 and MAPK pathways J Neurochem 123 2012 113 123
5. M. Cargnello, and P.P. Roux Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases Microbiol Mol Biol Rev 75 2011 50 83
6. H.S. Um, E.B. Kang, and J.H. Koo et al. Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer's disease Neurosci Res 69 2011 161 173
7. E.K. Kim, and E.J. Choi Pathological roles of MAPK signaling pathways in human diseases Biochim Biophys Acta 1802 2010 396 405
8. A. Sun, M. Liu, and X.V. Nguyen et al. P38 MAP kinase is activated at early stages in Alzheimer's disease brain Exp Neurol 183 2003 394 405
9. A.G. Pearson, U.T. Byrne, and G.A. MacGibbon et al. Activated c-Jun is present in neurofibrillary tangles in Alzheimer's disease brains Neurosci Lett 398 2006 246 250
10. I.G. Onyango, J.B. Tuttle, and J.P. Bennett Jr. Activation of p38 and N-acetylcysteine-sensitive c-Jun NH2-terminal kinase signaling cascades is required for induction of apoptosis in Parkinson's disease cybrids Mol Cell Neurosci 28 2005 452 461
11. J. Peng, and J.K. Andersen The role of c-Jun N-terminal kinase (JNK) in Parkinson's disease IUBMB Life 55 2003 267 271
12. A. Xuan, D. Long, and J. Li et al. Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer's disease J Neuroinflammation 9 2012 202
13. M.T. Armentero, E. Sinforiani, and C. Ghezzi et al. Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease Neurobiol Aging 32 2011 2142 2151
14. D. Uberti, C. Lanni, and M. Racchi et al. Conformationally altered p53: a putative peripheral marker for Alzheimer's disease Neurodegener Dis 5 2008 209 211
15. M. Morel, J. Couturier, and C. Lafay-Chebassier et al. PKR, the double stranded 15RNA-dependent protein kinase as a critical target in Alzheimer's disease J Cell Mol Med 13 2009 1476 1488
16. F. Liang, J. Jia, and S. Wang et al. Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer's disease J Clin Neurosci 20 2013 357 361
17. I. Mateo, J. Infante, and P. Sánchez-Juan et al. Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease Acta Neurol Scand 121 2010 136 138
18. G. Mckhann, D. Drachman, and M. Folstein et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease Neurology 34 1984 939 944
19. F. Blandini, F. Sinforiani, and C. Pacchetti et al. Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease Neurology 66 2006 529 534
20. K. Ono, and J. Han The p38 signal transduction pathway: activation and function Cell Signal 12 2000 1 13
21. R.K. Barr, and M.A. Bogoyevitch The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs) Int J Biochem Cell Biol 33 2001 1047 1063
22. Y. Mei, Z. Yuan, and B. Song et al. Activating transcription factor 3 up-regulated by c-Jun NH(2)-terminal kinase/c-Jun contributes to apoptosis induced by potassium deprivation in cerebellar granule neurons Neuroscience 151 2008 771 779
23. M.C. Barone, L.A. Desouza, and R.S. Freeman Pin1 promotes cell death in NGF-dependent neurons through a mechanism requiring c-Jun activity J Neurochem 106 2008 734 745
24. W. Cai, J.L. Rudolph, and T. Sengoku et al. Rit GTPase regulates a p38 MAPK-dependent neuronal survival pathway Neurosci Lett 531 2012 125 130
25. M. Tan, S. Wang, and J. Song et al. Combination of p53(ser15) and p21/p21(thr145) in peripheral blood lymphocytes as potential Alzheimer's disease biomarkers Neurosci Lett 516 2012 226 231
26. S. Lagalwar, A.L. Guillozet-Bongaarts, and R.W. Berry et al. Formation of phosphor-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease J Neuropathol Exp Neurol 65 2006 455 464
27. S. Mazzitelli, P. Xu, and I. Ferrer et al. The loss of c-Jun N-terminal protein kinase activity prevents the amyloidogenic cleavage of amyloid precursor protein and the formation of amyloid plaques in vivo J Neurosci 31 2011 16969 16976
28. G. Ashabi, M. Ramin, and P. Azizi et al. ERK and P38 inhibitors attenuate memory deficits and increase CREB phosphorylation and PGC-1a levels in Aβ-injected rats Behav Brain Res 232 2012 165 173
29. T. Sherrin, T. Blank, and C. Todorovic C-Jun N-terminal kinases in memory and synaptic plasticity Rev Neurosci 22 2011 403 410